Regulatory landscape of accelerated approval pathways for medical devices in the United States and the European Union.
PMID : 40444060 ·
T, a, n, v, i, , G, u, p, t, e, ;, , T, u, s, h, a, r, , N, i, t, a, v, e, ;, , J, o, g, a, r, a, o, , G, o, b, b, u, r, u
Publicité
Résumé
The landscape of medical device regulation is rapidly evolving, driven by innovations and the need to bring these technologies to patients more efficiently. This review provides a comprehensive analysis of the accelerated access pathways for medical devices in the United States (US) and the European Union (EU), focusing on the Breakthrough Devices Program (BDP) in the US and the evolving regulatory framework within the EU. Analysis of Food and Drug Administration (FDA) data reveals that from 201
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.